{"description":"Documents matching 'risk adjustment program well user'","count":10000,"total_pages":50,"next_page_url":"https://www.federalregister.gov/api/v1/documents?conditions%5Bterm%5D=risk+adjustment+program+well+user&format=json&page=2","results":[{"title":"Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program","type":"Proposed Rule","abstract":"This proposed rule contains provisions to improve implementation of the Patient Protection and Affordable Care Act, including payment parameters and provisions related to the HHS-operated risk adjustment and risk adjustment data validation (HHS-RADV) programs, as well as 2027 user fee rates for issuers offering qualified health plans (QHPs) through Federally-facilitated Exchanges (FFEs) and State-based Exchanges on the Federal platform (SBE-FPs). This proposed rule also includes provisions related to civil money penalties (CMPs) for noncompliant issuers and other responsible entities; standards governing agents, brokers, and web-brokers; the expansion and codification of hardship exemption eligibility; implementation of the State Exchange Improper Payment Measurement (SEIPM); provider access standards and essential community provider standards for QHP certification; QHP certification of non-network plans; a prohibition on issuers from including routine non-pediatric dental services as an Essential Health Benefit (EHB); cost-sharing flexibilities for catastrophic and individual market bronze plans; establishment of catastrophic plans with plan terms of up to 10 consecutive years; QHP issuer quality improvement strategies (QISs); revisions affecting which enrollees are included in Federal Basic Health Program (BHP) payment calculations to States; and seeks comment on potential adjustments to other Federal standards, including the Federal medical loss ratio (MLR) standard in the individual market. This proposed rule also includes amendments to implement certain provisions of the Working Families Tax Cut (WFTC) legislation.","document_number":"2026-02769","html_url":"https://www.federalregister.gov/documents/2026/02/11/2026-02769/patient-protection-and-affordable-care-act-hhs-notice-of-benefit-and-payment-parameters-for-2027-and","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-02-11/pdf/2026-02769.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-02769.pdf?1770671709","publication_date":"2026-02-11","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Centers for Medicare & Medicaid Services","name":"Centers for Medicare & Medicaid Services","id":45,"url":"https://www.federalregister.gov/agencies/centers-for-medicare-medicaid-services","json_url":"https://www.federalregister.gov/api/v1/agencies/45","parent_id":221,"slug":"centers-for-medicare-medicaid-services"},{"raw_name":"Office of the Secretary"}],"excerpts":"\n B. Part 153—Standards Related to Reinsurance, <span class=\"match\">Risk</span> Corridors, and <span class=\"match\">Risk</span> <span class=\"match\">Adjustment</span> \n \n In subparts A, B, D, G, and H of part 153, we established standards for the administration of the <span class=\"match\">risk</span> <span class=\"match\">adjustment</span> <span class=\"match\">program</span>. The <span class=\"match\">risk</span> <span class=\"match\">adjustment</span> <span class=\"match\">program</span> is a permanent <span class=\"match\">program</span> created by section 1343 of the Affordable Care Act that transfers funds from issuers of <span class=\"match\">risk</span> <span class=\"match\">adjustment</span> covered plans that have lower-than-average <span class=\"match\">risk</span> enrollees to issuers of <span class=\"match\">risk</span> <span class=\"match\">adjustment</span> covered plans that have higher-than-average <span class=\"match\">risk</span> enrollees, which includes issuers with plans in"},{"title":"Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program","type":"Rule","abstract":"This final rule contains provisions to improve implementation of the Patient Protection and Affordable Care Act, including payment parameters and provisions related to the HHS-operated risk adjustment and risk adjustment data validation (HHS-RADV) programs, as well as 2027 user fee rates for issuers offering qualified health plans (QHPs) through Federally-facilitated Exchanges (FFEs) and State-based Exchanges on the Federal platform (SBE-FPs). This final rule also includes provisions related to civil money penalties (CMPs) for noncompliant issuers and other responsible entities; standards governing agents, brokers, and web-brokers; the expansion and codification of hardship exemption eligibility; implementation of the State Exchange Improper Payment Measurement (SEIPM); provider access standards and essential community provider standards for QHP certification; QHP certification of non-network plans; a prohibition on issuers from including routine non-pediatric dental services as an Essential Health Benefit (EHB); requirements related to defrayal for the cost of any State-required benefits in addition to the EHB; cost- sharing flexibilities for catastrophic and individual market bronze plans; establishment of catastrophic plans with plan terms of up to 10 consecutive plan years; QHP issuer quality improvement strategies (QISs); and revisions affecting which enrollees are included in Federal Basic Health Program (BHP) payment calculations to States. This final rule also includes amendments to implement certain provisions of the Working Families Tax Cut (WFTC) legislation.","document_number":"2026-10050","html_url":"https://www.federalregister.gov/documents/2026/05/20/2026-10050/patient-protection-and-affordable-care-act-hhs-notice-of-benefit-and-payment-parameters-for-2027-and","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-05-20/pdf/2026-10050.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-10050.pdf?1779135308","publication_date":"2026-05-20","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Centers for Medicare & Medicaid Services","name":"Centers for Medicare & Medicaid Services","id":45,"url":"https://www.federalregister.gov/agencies/centers-for-medicare-medicaid-services","json_url":"https://www.federalregister.gov/api/v1/agencies/45","parent_id":221,"slug":"centers-for-medicare-medicaid-services"},{"raw_name":"Office of the Secretary"}],"excerpts":"\n B. Part 153—Standards Related to Reinsurance, <span class=\"match\">Risk</span> Corridors, and <span class=\"match\">Risk</span> <span class=\"match\">Adjustment</span> \n \n In subparts A, B, D, G, and H of part 153, we established standards for the administration of the <span class=\"match\">risk</span> <span class=\"match\">adjustment</span> <span class=\"match\">program</span>. The <span class=\"match\">risk</span> <span class=\"match\">adjustment</span> <span class=\"match\">program</span> is a permanent <span class=\"match\">program</span> created by section 1343 of the Affordable Care Act that transfers funds from issuers of <span class=\"match\">risk</span> <span class=\"match\">adjustment</span> covered plans that have lower-than-average <span class=\"match\">risk</span> enrollees to issuers of <span class=\"match\">risk</span> <span class=\"match\">adjustment</span> covered plans that have higher-than-average <span class=\"match\">risk</span> enrollees, which includes issuers with plans in"},{"title":"Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2026; and Basic Health Program","type":"Rule","abstract":"This final rule includes payment parameters and provisions related to the HHS-operated risk adjustment and risk adjustment data validation (HHS-RADV) programs, as well as 2026 benefit year user fee rates for issuers that participate in the HHS-operated risk adjustment program and the 2026 benefit year user fee rates for issuers offering qualified health plans (QHPs) through Federally-facilitated Exchanges (FFEs) and State-based Exchanges on the Federal platform (SBE-FPs). This final rule also includes requirements related to modifications to the calculation of the Basic Health Program (BHP) payment; and changes to the Initial Validation Audit (IVA) sampling approach and Second Validation Audit (SVA) pairwise means test for HHS-RADV. It also addresses HHS' authority to engage in compliance reviews of and take enforcement action against lead agents of insurance agencies for violations of HHS' Exchange standards and requirements; HHS' system suspension authority to address noncompliance by agents and brokers; an optional fixed-dollar premium payment threshold; permissible plan-level adjustment to the index rate to account for cost-sharing reductions (CSRs); reconsideration standards for certification denials; changes to the approach for conducting Essential Community Provider (ECP) certification reviews; a policy to publicly share aggregated, summary- level Quality Improvement Strategy (QIS) information on an annual basis; and revisions to the medical loss ratio (MLR) reporting and rebate requirements for qualifying issuers that meet certain standards.","document_number":"2025-00640","html_url":"https://www.federalregister.gov/documents/2025/01/15/2025-00640/patient-protection-and-affordable-care-act-hhs-notice-of-benefit-and-payment-parameters-for-2026-and","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-01-15/pdf/2025-00640.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-00640.pdf?1736802922","publication_date":"2025-01-15","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Office of the Secretary"}],"excerpts":"methodologies than cash assistance <span class=\"match\">program</span> methodologies in determining eligibility for certain eligibility groups. \n 1. Premium Stabilization <span class=\"match\">Programs</span> \n \n The premium stabilization <span class=\"match\">programs</span> refer to the <span class=\"match\">risk</span> <span class=\"match\">adjustment</span>, <span class=\"match\">risk</span> corridors, and reinsurance <span class=\"match\">programs</span> established by the ACA.\n 4 \n \n For past rulemaking, we refer readers to the following rules:\n \n \n \n 4 \n  See section 1341 of the ACA (transitional reinsurance <span class=\"match\">program</span>), section 1342 of the ACA (<span class=\"match\">risk</span> corridors <span class=\"match\">program</span>), and section 1343 of the ACA (<span class=\"match\">risk</span> <span class=\"match\">adjustment</span> <span class=\"match\">program</span>).\n \n \n \n • In the March 23"},{"title":"Veterinary Services User Fees","type":"Notice","abstract":"The Animal and Plant Health Inspection Service (APHIS) is announcing adjusted user fee rates for the costs of providing certain goods and services, including veterinary diagnostic goods and services and veterinary services for imports and exports of live animals and animal products. This action is necessary because the regulations provide that APHIS will issue such a notice. This action ensures that the fees charged more closely align with the costs of providing the goods or services, thus ensuring program solvency.","document_number":"2025-00421","html_url":"https://www.federalregister.gov/documents/2025/01/10/2025-00421/veterinary-services-user-fees","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-01-10/pdf/2025-00421.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-00421.pdf?1736343939","publication_date":"2025-01-10","agencies":[{"raw_name":"DEPARTMENT OF AGRICULTURE","name":"Agriculture Department","id":12,"url":"https://www.federalregister.gov/agencies/agriculture-department","json_url":"https://www.federalregister.gov/api/v1/agencies/12","parent_id":null,"slug":"agriculture-department"},{"raw_name":"Animal and Plant Health Inspection Service","name":"Animal and Plant Health Inspection Service","id":22,"url":"https://www.federalregister.gov/agencies/animal-and-plant-health-inspection-service","json_url":"https://www.federalregister.gov/api/v1/agencies/22","parent_id":12,"slug":"animal-and-plant-health-inspection-service"}],"excerpts":"specific nature of the increases; we therefore disagree that the proposed fee increases were an abrupt policy change. Moreover, as noted above, further delay of issuance of the <span class=\"match\">adjusted</span> fees runs the <span class=\"match\">risk</span> of disruption of the services provided or, in a worst-case scenario, <span class=\"match\">program</span> insolvency due to insufficient funds. Based on current and projected revenue, the <span class=\"match\">program</span> runs the <span class=\"match\">risk</span> of such disruptions if the fees are not increased by early spring 2025. \n Several commenters stated that APHIS should have engaged stakeholders prior to proposing to revise"},{"title":"Prescription Drug User Fee Rates for Fiscal Year 2026","type":"Notice","abstract":"The Food and Drug Administration (FDA, Agency, or we) is announcing the rates for prescription drug user fees for fiscal year (FY) 2026. The Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the Prescription Drug User Fee Amendments of 2022 (PDUFA VII), authorizes FDA to collect application fees for certain applications for the review of human drug and biological products and prescription drug program fees for certain approved products. This notice establishes the fee rates for FY 2026.","document_number":"2025-14413","html_url":"https://www.federalregister.gov/documents/2025/07/30/2025-14413/prescription-drug-user-fee-rates-for-fiscal-year-2026","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-07-30/pdf/2025-14413.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-14413.pdf?1753793115","publication_date":"2025-07-30","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"core review activities to improve their accuracy over time. An <span class=\"match\">adjustment</span> for workload has been a critical aspect of the PDUFA <span class=\"match\">program</span> since PDUFA III in FY 2003 as it enables the <span class=\"match\">program</span> to <span class=\"match\">adjust</span> to shifts in review workload resulting from industry submissions to the Agency. The annual <span class=\"match\">adjustment</span> process allows greater accuracy than would be expected if workload <span class=\"match\">adjustments</span> were fixed at the start of the reauthorization period. The CPA is an evolution of the PDUFA workload <span class=\"match\">adjuster</span> and was implemented through a process agreed to by FDA and industry"},{"title":"Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2026; and Basic Health Program","type":"Proposed Rule","abstract":"This proposed rule includes payment parameters and provisions related to the HHS-operated risk adjustment and risk adjustment data validation (HHS-RADV) programs, as well as 2026 benefit year user fee rates for issuers that participate in the HHS-operated risk adjustment program and the 2026 benefit year user fee rates for issuers offering qualified health plans (QHPs) through Federally-facilitated Exchanges (FFEs) and State-based Exchanges on the Federal platform (SBE-FPs). This proposed rule also includes proposed requirements related to modifications to the calculation of the Basic Health Program (BHP) payment; and changes to the Initial Validation Audit (IVA) sampling approach and Second Validation Audit (SVA) pairwise means test for HHS- RADV. It also addresses HHS' authority to engage in compliance reviews of and take enforcement action against lead agents of insurance agencies for violations of HHS' Exchange standards and requirements; HHS' system suspension authority to address noncompliance by agents and brokers; an optional fixed-dollar premium payment threshold; proposed reconsideration standards for certification denials; proposed changes to the approach for conducting Essential Community Provider (ECP) certification reviews; a proposal to publicly share aggregated, summary-level Quality Improvement Strategy (QIS) information on an annual basis; and proposed revisions to the medical loss ratio (MLR) reporting and rebate requirements for qualifying issuers that meet certain standards.","document_number":"2024-23103","html_url":"https://www.federalregister.gov/documents/2024/10/10/2024-23103/patient-protection-and-affordable-care-act-hhs-notice-of-benefit-and-payment-parameters-for-2026-and","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-10-10/pdf/2024-23103.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-23103.pdf?1728072923","publication_date":"2024-10-10","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Centers for Medicare & Medicaid Services","name":"Centers for Medicare & Medicaid Services","id":45,"url":"https://www.federalregister.gov/agencies/centers-for-medicare-medicaid-services","json_url":"https://www.federalregister.gov/api/v1/agencies/45","parent_id":221,"slug":"centers-for-medicare-medicaid-services"},{"raw_name":"Office of the Secretary"}],"excerpts":"methodologies than cash assistance <span class=\"match\">program</span> methodologies in determining eligibility for certain eligibility groups. \n 1. Premium Stabilization <span class=\"match\">Programs</span> \n \n The premium stabilization <span class=\"match\">programs</span> refer to the <span class=\"match\">risk</span> <span class=\"match\">adjustment</span>, <span class=\"match\">risk</span> corridors, and reinsurance <span class=\"match\">programs</span> established by the ACA.\n 4 \n \n For past rulemaking, we refer readers to the following rules:\n \n \n \n 4 \n  See section 1341 of the ACA (transitional reinsurance <span class=\"match\">program</span>), section 1342 of the ACA (<span class=\"match\">risk</span> corridors <span class=\"match\">program</span>), and section 1343 of the ACA (<span class=\"match\">risk</span> <span class=\"match\">adjustment</span> <span class=\"match\">program</span>).\n \n \n \n • In the March 23"},{"title":"Generic Drug User Fee Rates for Fiscal Year 2026","type":"Notice","abstract":"The Federal Food, Drug, and Cosmetic Act (FD&C Act or statute), as amended by the Generic Drug User Fee Amendments of 2022 (GDUFA III), authorizes the Food and Drug Administration (FDA, Agency, or we) to assess and collect fees for abbreviated new drug applications (ANDAs); drug master files (DMFs); generic drug active pharmaceutical ingredient (API) facilities, finished dosage form (FDF) facilities, and contract manufacturing organization (CMO) facilities; and generic drug applicant program user fees. In this document, FDA is announcing fiscal year (FY) 2026 rates for GDUFA III fees.","document_number":"2025-14411","html_url":"https://www.federalregister.gov/documents/2025/07/30/2025-14411/generic-drug-user-fee-rates-for-fiscal-year-2026","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-07-30/pdf/2025-14411.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-14411.pdf?1753793114","publication_date":"2025-07-30","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"FDA shall, in addition to the inflation <span class=\"match\">adjustment</span>, apply a capacity planning <span class=\"match\">adjustment</span> to further <span class=\"match\">adjust</span>, as needed, the fee revenue and fees to reflect changes in the resource capacity needs of FDA for human generic drug activities. \n Under section 744B(c)(3) of the FD&amp;C Act, for FY 2026, FDA may, in addition to the inflation and capacity planning <span class=\"match\">adjustments</span>, apply an operating reserve <span class=\"match\">adjustment</span> to further increase the fee revenue and fees if necessary to provide operating reserves of carryover <span class=\"match\">user</span> fees for human generic drug activities"},{"title":"Over-the-Counter Monograph Drug User Fee Program-Facility Fee Rates for Fiscal Year 2025","type":"Notice","abstract":"The Food and Drug Administration (FDA, the Agency, or we) is announcing the over-the-counter (OTC) monograph drug facility (MDF) fee rates under the OTC monograph drug user fee program (OMUFA) for fiscal year (FY) 2025. The Federal Food, Drug, and Cosmetic Act (FD&C Act) authorizes FDA to assess and collect user fees from qualifying manufacturers of OTC monograph drugs and submitters of OTC monograph order requests (OMORs). This notice publishes the OMUFA facility fee rates for FY 2025.","document_number":"2025-04860","html_url":"https://www.federalregister.gov/documents/2025/03/21/2025-04860/over-the-counter-monograph-drug-user-fee-program-facility-fee-rates-for-fiscal-year-2025","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-03-21/pdf/2025-04860.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-04860.pdf?1742474715","publication_date":"2025-03-21","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"without certain <span class=\"match\">adjustments</span> made for that previous year, and is $29,253,365 (see section 744M(b)(3)(B) of the FD&amp;C Act). \n B. Fee Revenue <span class=\"match\">Adjustment</span> for Inflation \n Under OMUFA, the annual base revenue amount for facility fees is <span class=\"match\">adjusted</span> for inflation for FY 2025, per section 744M(c)(1) of the FD&amp;C Act. That provision states that the dollar amount of the inflation <span class=\"match\">adjustment</span> is equal to the product of the annual base revenue for the fiscal year and the inflation <span class=\"match\">adjustment</span> percentage. For FY 2025 the inflation <span class=\"match\">adjustment</span> percentage is the"},{"title":"Changes to Agriculture Risk Coverage, Price Loss Coverage, and Dairy Margin Coverage Programs","type":"Rule","abstract":"This rule revises the provisions of the Agriculture Risk Coverage (ARC), Price Loss Coverage (PLC), and Dairy Margin Coverage (DMC) programs to conform with provisions of the One Big Beautiful Bill Act (OBBBA). OBBBA authorized modifications to the 2025 crop year ARC and PLC programs and the continuation of the ARC and PLC programs for the 2026 through 2031 crop years. The modified provisions are related to the reference prices, the effective reference prices, base acres, program elections, and payment provisions. OBBBA also authorized DMC for calendar years 2026 through 2031, providing participating dairy operations with the ability to establish a new production history. In addition, the Tier 1 coverage level was increased by 1 million pounds of milk to a 6-million-pound limit and eligibility for multi-year (lock-in) contracts was maintained until December 30, 2031. The Farm Service Agency (FSA) is also making minor administrative changes and updates to the ARC, PLC, and DMC regulations and the regulations that apply to multiple FSA programs.","document_number":"2026-00313","html_url":"https://www.federalregister.gov/documents/2026/01/12/2026-00313/changes-to-agriculture-risk-coverage-price-loss-coverage-and-dairy-margin-coverage-programs","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-01-12/pdf/2026-00313.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-00313.pdf?1767966310","publication_date":"2026-01-12","agencies":[{"raw_name":"DEPARTMENT OF AGRICULTURE","name":"Agriculture Department","id":12,"url":"https://www.federalregister.gov/agencies/agriculture-department","json_url":"https://www.federalregister.gov/api/v1/agencies/12","parent_id":null,"slug":"agriculture-department"},{"raw_name":"Farm Service Agency","name":"Farm Service Agency","id":157,"url":"https://www.federalregister.gov/agencies/farm-service-agency","json_url":"https://www.federalregister.gov/api/v1/agencies/157","parent_id":12,"slug":"farm-service-agency"},{"raw_name":"Commodity Credit Corporation","name":"Commodity Credit Corporation","id":76,"url":"https://www.federalregister.gov/agencies/commodity-credit-corporation","json_url":"https://www.federalregister.gov/api/v1/agencies/76","parent_id":12,"slug":"commodity-credit-corporation"}],"excerpts":"Assistance <span class=\"match\">Programs</span> \n The titles and numbers of the Federal assistance <span class=\"match\">programs</span>, as found in the Assistance Listing, to which this document applies are 10.112—Price Loss Coverage, 10.113—Agriculture <span class=\"match\">Risk</span> Coverage, and 10.127—Dairy Margin Coverage. \n \n List of Subjects \n \n Acreage allotments, Drug traffic control, Loan <span class=\"match\">programs</span>—agriculture, Marketing quotas, Price support <span class=\"match\">programs</span>, Reporting and recordkeeping requirements. \n \n Agriculture, Grant <span class=\"match\">programs</span>—agriculture, Loan <span class=\"match\">programs</span>—agriculture, Natural resources, Price support <span class=\"match\">programs</span>. \n \n Acreage"},{"title":"Regulatory Capital Rule (Regulation Q): Risk-Based Capital Surcharges for Global Systemically Important Bank Holding Companies; Systemic Risk Report (FR Y-15)","type":"Proposed Rule","abstract":"The Board of Governors of the Federal Reserve System (Board) is inviting public comment on a notice of proposed rulemaking to amend the Board's rule that identifies and establishes risk-based capital surcharges for U.S. global systemically important bank holding companies (GSIBs). The proposal would also amend the Systemic Risk Report (FR Y-15), which is the source of inputs to the implementation of the GSIB framework under the capital rule. The proposal would make several changes to better align surcharges with risk. First, it would modify certain coefficients used to calculate GSIB surcharges under method 2 of the GSIB surcharge framework to reflect changes in the financial system and the economy and provide for annual adjustments for real economic growth and inflation going forward. Second, the proposal would modify the measurement and weighting of the weighted short-term wholesale funding systemic indicator. Third, for certain systemic indicators currently measured as of a single date each year, the proposal would require measurement based on average values to reduce the effects of temporary changes to indicator values around measurement dates. Fourth, the proposal would reduce cliff effects and enhance the sensitivity of the surcharge to changes in a GSIB's systemic risk profile. Fifth, to improve risk capture, the proposal would also make improvements to the measurement of some systemic indicators used in the GSIB surcharge framework and the framework for determining prudential standards for large banking organizations. In addition to these changes, the proposal would make several amendments to the FR Y-15 to improve the consistency of data reporting and streamline the reporting process.","document_number":"2026-05961","html_url":"https://www.federalregister.gov/documents/2026/03/27/2026-05961/regulatory-capital-rule-regulation-q-risk-based-capital-surcharges-for-global-systemically-important","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-03-27/pdf/2026-05961.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-05961.pdf?1774529110","publication_date":"2026-03-27","agencies":[{"raw_name":"FEDERAL RESERVE SYSTEM","name":"Federal Reserve System","id":188,"url":"https://www.federalregister.gov/agencies/federal-reserve-system","json_url":"https://www.federalregister.gov/api/v1/agencies/188","parent_id":null,"slug":"federal-reserve-system"}],"excerpts":"data collected on the FR Y-15 are used to identify other firms that may present significant systemic <span class=\"match\">risk</span> and to analyze the systemic <span class=\"match\">risk</span> implications of proposed mergers and acquisitions. \n C. Overview of the Proposal \n \n The proposal includes revisions to the GSIB framework that would improve the framework's measurement of systemic <span class=\"match\">risk</span> and better align GSIB surcharges with firms' systemic <span class=\"match\">risk</span> profiles.\n 21 \n \n First, the proposal would <span class=\"match\">adjust</span> the fixed coefficients in the method 2 GSIB surcharge framework to account for changes in the financial"},{"title":"Reauthorization of the Prescription Drug User Fee Act; Public Meeting; Request for Comments","type":"Notice","abstract":"The Food and Drug Administration (FDA, the Agency, or we) is hosting a public meeting to discuss proposed recommendations for the reauthorization of the Prescription Drug User Fee Act (PDUFA) for fiscal years (FYs) 2028 through 2032. PDUFA authorizes FDA to collect user fees to support the process for the review of human drug applications. The current legislative authority for PDUFA expires in September 2027. At that time, new legislation will be required for FDA to continue collecting prescription drug user fees in future fiscal years. The Federal Food, Drug, and Cosmetic Act (FD&C Act) directs that FDA begin the PDUFA reauthorization process by publishing a notice in the Federal Register requesting public input and holding a public meeting where the public may present its views on the reauthorization. FDA invites public comment as the Agency begins the process to reauthorize the program in FYs 2028 through 2032. These comments will be published and available on FDA's website.","document_number":"2025-08824","html_url":"https://www.federalregister.gov/documents/2025/05/19/2025-08824/reauthorization-of-the-prescription-drug-user-fee-act-public-meeting-request-for-comments","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-05-19/pdf/2025-08824.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-08824.pdf?1747399510","publication_date":"2025-05-19","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"financial footing and support for limited postmarket <span class=\"match\">risk</span> management were key themes of PDUFA III. Base <span class=\"match\">user</span> fee resources were significantly increased and a mechanism to account for changes in human drug review workload was adopted. PDUFA III also expanded the scope of <span class=\"match\">user</span> fee activities to include postmarket surveillance of new therapies for up to 3 years after marketing approval. FDA committed to the development of guidance for industry on <span class=\"match\">risk</span> assessment, <span class=\"match\">risk</span> management, and pharmacovigilance, as <span class=\"match\">well</span> as guidance to review staff and industry on good"},{"title":"Prohibition on the Use of Reputation Risk by Regulators","type":"Rule","abstract":"The Office of the Comptroller of the Currency and the Federal Deposit Insurance Corporation are adopting a final rule to codify the elimination of reputation risk from their supervisory programs. Among other things, the rule prohibits the agencies from criticizing or taking adverse action against an institution on the basis of reputation risk. The rule also prohibits the agencies from requiring, instructing, or encouraging an institution to close an account, to refrain from providing an account, product, or service, or to modify or terminate any product or service on the basis of a person or entity's political, social, cultural, or religious views or beliefs, constitutionally protected speech, or solely on the basis of politically disfavored but lawful business activities perceived to present reputation risk. The rule further forbids the agencies from taking any supervisory action or other adverse action against an institution, a group of institutions, or the institution-affiliated parties of any institution that is designed to punish or discourage an individual or group from engaging in any lawful political, social, cultural, or religious activities, constitutionally protected speech, or, for political reasons, lawful business activities that the agencies or its personnel disagree with or disfavor.","document_number":"2026-06947","html_url":"https://www.federalregister.gov/documents/2026/04/10/2026-06947/prohibition-on-the-use-of-reputation-risk-by-regulators","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-04-10/pdf/2026-06947.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-06947.pdf?1775738713","publication_date":"2026-04-10","agencies":[{"raw_name":"DEPARTMENT OF THE TREASURY","name":"Treasury Department","id":497,"url":"https://www.federalregister.gov/agencies/treasury-department","json_url":"https://www.federalregister.gov/api/v1/agencies/497","parent_id":null,"slug":"treasury-department"},{"raw_name":"Office of the Comptroller of the Currency","name":"Comptroller of the Currency","id":80,"url":"https://www.federalregister.gov/agencies/comptroller-of-the-currency","json_url":"https://www.federalregister.gov/api/v1/agencies/80","parent_id":497,"slug":"comptroller-of-the-currency"},{"raw_name":"FEDERAL DEPOSIT INSURANCE CORPORATION","name":"Federal Deposit Insurance Corporation","id":164,"url":"https://www.federalregister.gov/agencies/federal-deposit-insurance-corporation","json_url":"https://www.federalregister.gov/api/v1/agencies/164","parent_id":null,"slug":"federal-deposit-insurance-corporation"}],"excerpts":"interest rate <span class=\"match\">risk</span>, liquidity <span class=\"match\">risk</span>, price <span class=\"match\">risk</span>, foreign exchange <span class=\"match\">risk</span>, transaction <span class=\"match\">risk</span>, compliance <span class=\"match\">risk</span>, strategic <span class=\"match\">risk</span>, and reputation <span class=\"match\">risk</span>. The <span class=\"match\">program</span> later morphed into the OCC's current <span class=\"match\">risk</span>-based framework, which focuses on eight <span class=\"match\">risk</span> categories, with transaction <span class=\"match\">risk</span> renamed as operational <span class=\"match\">risk</span> and foreign exchange <span class=\"match\">risk</span> eliminated as a stand-alone <span class=\"match\">risk</span>. This <span class=\"match\">risk</span>-based supervision <span class=\"match\">program</span> focuses on evaluating <span class=\"match\">risk</span>, identifying existing and emerging problems, and ensuring that bank management takes corrective action to address problems before"},{"title":"Prohibition on Use of Reputation Risk by Regulators","type":"Proposed Rule","abstract":"The Office of the Comptroller of the Currency (OCC) and the Federal Deposit Insurance Corporation (FDIC) (collectively, the agencies) are issuing a notice of proposed rulemaking to codify the elimination of reputation risk from their supervisory programs. Among other things, the proposed rule would prohibit the agencies from criticizing or taking adverse action against an institution on the basis of reputation risk. The proposed rule would also prohibit the agencies from requiring, instructing, or encouraging an institution to close an account, to refrain from providing an account, product, or service, or to modify or terminate any product or service on the basis of a person or entity's political, social, cultural, or religious views or beliefs, constitutionally protected speech, or solely on the basis of politically disfavored but lawful business activities perceived to present reputation risk.","document_number":"2025-19715","html_url":"https://www.federalregister.gov/documents/2025/10/30/2025-19715/prohibition-on-use-of-reputation-risk-by-regulators","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-10-30/pdf/2025-19715.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-19715.pdf?1761741909","publication_date":"2025-10-30","agencies":[{"raw_name":"DEPARTMENT OF THE TREASURY","name":"Treasury Department","id":497,"url":"https://www.federalregister.gov/agencies/treasury-department","json_url":"https://www.federalregister.gov/api/v1/agencies/497","parent_id":null,"slug":"treasury-department"},{"raw_name":"Office of the Comptroller of the Currency","name":"Comptroller of the Currency","id":80,"url":"https://www.federalregister.gov/agencies/comptroller-of-the-currency","json_url":"https://www.federalregister.gov/api/v1/agencies/80","parent_id":497,"slug":"comptroller-of-the-currency"},{"raw_name":"FEDERAL DEPOSIT INSURANCE CORPORATION","name":"Federal Deposit Insurance Corporation","id":164,"url":"https://www.federalregister.gov/agencies/federal-deposit-insurance-corporation","json_url":"https://www.federalregister.gov/api/v1/agencies/164","parent_id":null,"slug":"federal-deposit-insurance-corporation"}],"excerpts":"interest rate <span class=\"match\">risk</span>, liquidity <span class=\"match\">risk</span>, price <span class=\"match\">risk</span>, foreign exchange <span class=\"match\">risk</span>, transaction <span class=\"match\">risk</span>, compliance <span class=\"match\">risk</span>, strategic <span class=\"match\">risk</span>, and reputation <span class=\"match\">risk</span>. The <span class=\"match\">program</span> later morphed into the OCC's current <span class=\"match\">risk</span>-based framework, which focuses on eight <span class=\"match\">risk</span> categories, with transaction <span class=\"match\">risk</span> renamed as operational <span class=\"match\">risk</span> and foreign exchange <span class=\"match\">risk</span> eliminated as a stand-alone <span class=\"match\">risk</span>. This <span class=\"match\">risk</span>-based supervision <span class=\"match\">program</span> focuses on evaluating <span class=\"match\">risk</span>, identifying existing and emerging problems, and ensuring that bank management takes corrective action to address problems before"},{"title":"Expanding Access to Risk Protection (EARP)","type":"Rule","abstract":"The Federal Crop Insurance Corporation (FCIC) is amending its regulations to implement changes required by the One Big Beautiful Bill Act and to update, streamline, and clarify several crop insurance policies. The changes include clarifying the harvest price methodology, deregulating regionalized program dates and moving that information to the Special Provisions, removing regulatory barriers to direct marketing, incorporating quality adjustment and claims processes, updating FCIC contact information used to request interpretations of policy, and making plain language clarifications and corrections to Subpart X--Interpretations of Statutory Provisions, Policy Provisions, and Procedures; the Area Risk Protection Insurance, Basic Provisions; the Common Crop Insurance Policy, Basic Provisions; and several Crop Provisions. In addition, the changes include removing buy-up coverage for prevented planting in the crop insurance program. The changes will be effective for the 2026 and succeeding crop years for crops with a contract change date on or after November 30, 2025. For all other crops, the changes to the policies made in this rule are applicable for the 2027 and succeeding crop years.","document_number":"2025-21482","html_url":"https://www.federalregister.gov/documents/2025/11/28/2025-21482/expanding-access-to-risk-protection-earp","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-11-28/pdf/2025-21482.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-21482.pdf?1764164732","publication_date":"2025-11-28","agencies":[{"raw_name":"DEPARTMENT OF AGRICULTURE","name":"Agriculture Department","id":12,"url":"https://www.federalregister.gov/agencies/agriculture-department","json_url":"https://www.federalregister.gov/api/v1/agencies/12","parent_id":null,"slug":"agriculture-department"},{"raw_name":"Federal Crop Insurance Corporation","name":"Federal Crop Insurance Corporation","id":163,"url":"https://www.federalregister.gov/agencies/federal-crop-insurance-corporation","json_url":"https://www.federalregister.gov/api/v1/agencies/163","parent_id":12,"slug":"federal-crop-insurance-corporation"}],"excerpts":"regarding quality <span class=\"match\">adjustment</span> into section 10 (Settlement of Claim) of the Crop Provisions. This rule does not change the quality <span class=\"match\">adjustment</span> or claims process that has been in place since the 2018 crop year, but rather, moves the quality <span class=\"match\">adjustment</span> calculation to the Crop Provisions. \n Adverse weather conditions impacting cotton producers in the Southeast in 2015 and 2016 resulted in complaints that FCIC's cotton quality <span class=\"match\">adjustment</span> did not meet the needs of producers. This led to a request for FCIC to consider alternative methods for <span class=\"match\">adjusting</span> poor quality"},{"title":"Revising Definition of “Unlawful User of or Addicted to Controlled Substance”","type":"Rule","abstract":"The Bureau of Alcohol, Tobacco, Firearms, and Explosives (\"ATF\") is amending Department of Justice (\"Department\") regulations to update the definition of \"unlawful user of or addicted to any controlled substance,\" a category of persons who may not possess firearms under federal law. This definition was established in 1996 to facilitate operation of the National Instant Criminal Background Check System. Since then, court decisions and ATF internal guidance have evolved to include recurring use as a factor. As a result, ATF is aligning the definition with the best statutory understanding, as informed by judicial decisions.","document_number":"2026-01141","html_url":"https://www.federalregister.gov/documents/2026/01/22/2026-01141/revising-definition-of-unlawful-user-of-or-addicted-to-controlled-substance","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-01-22/pdf/2026-01141.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-01141.pdf?1768925707","publication_date":"2026-01-22","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Bureau of Alcohol, Tobacco, Firearms, and Explosives","name":"Alcohol, Tobacco, Firearms, and Explosives Bureau","id":19,"url":"https://www.federalregister.gov/agencies/alcohol-tobacco-firearms-and-explosives-bureau","json_url":"https://www.federalregister.gov/api/v1/agencies/19","parent_id":268,"slug":"alcohol-tobacco-firearms-and-explosives-bureau"}],"excerpts":"who is an unlawful <span class=\"match\">user</span> of or addicted to any controlled substance (as defined by section 102 of the Controlled Substances Act at 21 U.S.C. 802) to ship, transport, possess, or receive any firearm that has moved through interstate or foreign commerce. In other words, persons who are unlawful <span class=\"match\">users</span> of or addicted to a controlled substance constitute one category of what are commonly referred to as “prohibited” persons in the context of firearms. The plain language of the text indicates that the person must be a current unlawful <span class=\"match\">user</span> of a controlled"},{"title":"Regulatory Capital Rules: Regulatory Capital and Standardized Approach for Risk-Weighted Assets","type":"Proposed Rule","abstract":"The Office of the Comptroller of the Currency, the Board of Governors of the Federal Reserve System, and the Federal Deposit Insurance Corporation are proposing to modify certain aspects of the regulatory capital rule (the proposal). The proposal would revise the risk-based capital treatment of certain exposure categories under the standardized approach, focusing on improving the calibration and risk sensitivity of risk weights that are particularly material to covered banking organizations' lending activities. The proposal would also modify the definition of regulatory capital by removing the threshold- based deduction for mortgage servicing assets for all banking organizations subject to the regulatory capital rule, including banking organizations subject to the community bank leverage ratio framework. In addition, the proposal would require Category III and IV banking organizations to recognize most elements of accumulated other comprehensive income in their regulatory capital. The agencies are concurrently publishing a separate proposal, which would require Category I and II banking organizations to use a new framework to calculate risk-weighted assets, called the expanded risk-based approach and would allow other banking organizations to elect to use the expanded risk-based approach.","document_number":"2026-05960","html_url":"https://www.federalregister.gov/documents/2026/03/27/2026-05960/regulatory-capital-rules-regulatory-capital-and-standardized-approach-for-risk-weighted-assets","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-03-27/pdf/2026-05960.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-05960.pdf?1774529110","publication_date":"2026-03-27","agencies":[{"raw_name":"DEPARTMENT OF THE TREASURY","name":"Treasury Department","id":497,"url":"https://www.federalregister.gov/agencies/treasury-department","json_url":"https://www.federalregister.gov/api/v1/agencies/497","parent_id":null,"slug":"treasury-department"},{"raw_name":"Office of the Comptroller of the Currency","name":"Comptroller of the Currency","id":80,"url":"https://www.federalregister.gov/agencies/comptroller-of-the-currency","json_url":"https://www.federalregister.gov/api/v1/agencies/80","parent_id":497,"slug":"comptroller-of-the-currency"},{"raw_name":"FEDERAL RESERVE SYSTEM","name":"Federal Reserve System","id":188,"url":"https://www.federalregister.gov/agencies/federal-reserve-system","json_url":"https://www.federalregister.gov/api/v1/agencies/188","parent_id":null,"slug":"federal-reserve-system"},{"raw_name":"FEDERAL DEPOSIT INSURANCE CORPORATION","name":"Federal Deposit Insurance Corporation","id":164,"url":"https://www.federalregister.gov/agencies/federal-deposit-insurance-corporation","json_url":"https://www.federalregister.gov/api/v1/agencies/164","parent_id":null,"slug":"federal-deposit-insurance-corporation"}],"excerpts":"also make targeted <span class=\"match\">adjustments</span> to the existing methodologies for determining exposure amounts for counterparty credit <span class=\"match\">risk</span> and <span class=\"match\">risk</span>-weighted asset amounts for securitizations, as <span class=\"match\">well</span> as for recognizing the benefits of credit <span class=\"match\">risk</span> mitigants. These targeted <span class=\"match\">adjustments</span> would align with <span class=\"match\">adjustments</span> included in the expanded <span class=\"match\">risk</span>-based proposal. Improving the <span class=\"match\">risk</span> sensitivity of the regulatory capital framework would mean that a banking organization's capital requirements more readily increase or decrease due to changes in the <span class=\"match\">risk</span> of its business activities"},{"title":"Reauthorization of the Over-The-Counter Monograph Drug User Fee Program; Public Meeting; Request for Comments","type":"Notice","abstract":"The Food and Drug Administration (FDA, the Agency, or we) is hosting a public meeting to discuss proposed recommendations for the reauthorization of the Over-The-Counter [OTC] Monograph Drug User Fee Program (OMUFA) for fiscal years (FYs) 2026 through 2030. Under OMUFA, FDA collects user fees to support OTC monograph drug activities. The current legislative authority for OMUFA expires September 30, 2025. At that time, new legislation will be required to reauthorize OMUFA for future fiscal years. Following negotiations with the regulated industry and consultation with interested members of the public, the Federal Food, Drug, and Cosmetic Act (FD&C Act) directs FDA to publish recommendations for the reauthorization of the OMUFA program in the Federal Register, provide for a period of 30 days for the public to provide written comments on such recommendations, and hold a meeting at which the public may present its views on such recommendations. FDA will then consider such public views and comments and revise such recommendations as necessary.","document_number":"2024-25458","html_url":"https://www.federalregister.gov/documents/2024/11/01/2024-25458/reauthorization-of-the-over-the-counter-monograph-drug-user-fee-program-public-meeting-request-for","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-11-01/pdf/2024-25458.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-25458.pdf?1730378728","publication_date":"2024-11-01","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"they meet the requirements of section 505G of the FD&amp;C Act (21 U.S.C. 355g), as <span class=\"match\">well</span> as other applicable requirements. Accompanying this OTC monograph reform legislation were provisions added by the CARES Act to the FD&amp;C Act authorizing FDA to assess and collect <span class=\"match\">user</span> fees dedicated to OTC monograph drug activities.\n \n This <span class=\"match\">user</span> fee <span class=\"match\">program</span> with respect to OTC monograph drugs, which we refer to as OMUFA, is modeled after the successful Prescription Drug <span class=\"match\">User</span> Fee Act (PDUFA). For OMUFA purposes, industry-paid fees help support FDA's OTC monograph"},{"title":"Pipeline Safety: Adjustment to OPID Notifications for Construction","type":"Proposed Rule","abstract":"This NPRM proposes to increase the monetary threshold for Operator Identification Number notifications for certain construction and maintenance tasks on gas and hazardous liquid and carbon dioxide pipeline facilities. PHMSA is also proposing to adjust inflation adjustment procedures to provide a mechanism for updating these thresholds on an annual basis.","document_number":"2026-08082","html_url":"https://www.federalregister.gov/documents/2026/04/24/2026-08082/pipeline-safety-adjustment-to-opid-notifications-for-construction","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-04-24/pdf/2026-08082.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-08082.pdf?1776948325","publication_date":"2026-04-24","agencies":[{"raw_name":"DEPARTMENT OF TRANSPORTATION","name":"Transportation Department","id":492,"url":"https://www.federalregister.gov/agencies/transportation-department","json_url":"https://www.federalregister.gov/api/v1/agencies/492","parent_id":null,"slug":"transportation-department"},{"raw_name":"Pipeline and Hazardous Materials Safety Administration","name":"Pipeline and Hazardous Materials Safety Administration","id":408,"url":"https://www.federalregister.gov/agencies/pipeline-and-hazardous-materials-safety-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/408","parent_id":492,"slug":"pipeline-and-hazardous-materials-safety-administration"}],"excerpts":" \n \n SUMMARY: \n This NPRM proposes to increase the monetary threshold for Operator Identification Number notifications for certain construction and maintenance tasks on gas and hazardous liquid and carbon dioxide pipeline facilities. PHMSA is also proposing to <span class=\"match\">adjust</span> inflation <span class=\"match\">adjustment</span> procedures to provide a mechanism for updating these thresholds on an annual basis. \n \n \n DATES: \n Comments must be received on or before June 23, 2026. \n \n \n ADDRESSES: \n You may submit comments identified by the Docket Number PHMSA-2026-1551 using any of the following"},{"title":"Accidental Release Prevention Requirements: Risk Management Programs Under the Clean Air Act; Common Sense Approach to Chemical Accident Prevention","type":"Proposed Rule","abstract":"The U.S. Environmental Protection Agency (EPA or Agency) is proposing to amend its Risk Management Program (RMP) regulations by making several proposed changes to the 2024 Safer Communities by Chemical Accident Prevention (SCCAP) rule. The proposed revisions include changes to provisions relating to safer technology and alternatives analyses, information availability, third-party audits, employee participation, community and emergency responder notification, stationary source siting, natural hazards, power loss, declined recommendations documentation, emergency response exercises, process safety information (PSI) and recognized and generally accepted good engineering practices (RAGAGEP), deregistration form information collection, hot work permit retention, and the retail facility definition. These proposed amendments seek to improve chemical process safety by avoiding duplicative requirements, realigning RMP requirements with Occupational Safety and Health Administration (OSHA) Process Safety Management (PSM) requirements, and eliminating unnecessary burdens placed on facilities where there is not specific data available to show that the current RMP standards would reduce or have reduced the number of accidental releases.","document_number":"2026-03633","html_url":"https://www.federalregister.gov/documents/2026/02/24/2026-03633/accidental-release-prevention-requirements-risk-management-programs-under-the-clean-air-act-common","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-02-24/pdf/2026-03633.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-03633.pdf?1771854312","publication_date":"2026-02-24","agencies":[{"raw_name":"ENVIRONMENTAL PROTECTION AGENCY","name":"Environmental Protection Agency","id":145,"url":"https://www.federalregister.gov/agencies/environmental-protection-agency","json_url":"https://www.federalregister.gov/api/v1/agencies/145","parent_id":null,"slug":"environmental-protection-agency"}],"excerpts":"assessment, documenting a management system, implementing a prevention <span class=\"match\">program</span> and an emergency response <span class=\"match\">program</span>, and submitting a <span class=\"match\">risk</span> management plan that addresses all aspects of the <span class=\"match\">risk</span> management <span class=\"match\">program</span> for all covered processes and chemicals. A process at a source is covered under one of three different prevention <span class=\"match\">programs</span> (<span class=\"match\">Program</span> 1, <span class=\"match\">Program</span> 2, or <span class=\"match\">Program</span> 3) based directly or indirectly on the threat posed to the community and the environment by an accidental release. <span class=\"match\">Program</span> 1 has minimal requirements and applies to processes that have not"},{"title":"Expansion of Validated End User Authorization: Data Center Validated End User Authorization","type":"Rule","abstract":"In this rule, the Department of Commerce, Bureau of Industry and Security (BIS), amends the Export Administration Regulations (EAR) to expand the Validated End User Authorization (VEU) program to include VEU Authorization for data centers located in specified destinations (\"Data Center VEU\" or \"Data Center VEU Authorization\"). This expansion of the VEU program to include Data Center VEU is intended to facilitate quick and reliable export or reexport of items on the Commerce Control List necessary for a data center, including advanced computing items, to preapproved trusted end users. Data Center VEU adopts much of the framework of the existing VEU program, with additional requirements. This expansion of eligibility is intended to update the VEU program to recognize the advancement and benefits of artificial intelligence. As under the original VEU Authorization Program, the U.S. government will rigorously review Data Center VEU candidates' applications subject to detailed and verifiable criteria.","document_number":"2024-22587","html_url":"https://www.federalregister.gov/documents/2024/10/02/2024-22587/expansion-of-validated-end-user-authorization-data-center-validated-end-user-authorization","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-10-02/pdf/2024-22587.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-22587.pdf?1727700348","publication_date":"2024-10-02","agencies":[{"raw_name":"DEPARTMENT OF COMMERCE","name":"Commerce Department","id":54,"url":"https://www.federalregister.gov/agencies/commerce-department","json_url":"https://www.federalregister.gov/api/v1/agencies/54","parent_id":null,"slug":"commerce-department"},{"raw_name":"Bureau of Industry and Security","name":"Industry and Security Bureau","id":241,"url":"https://www.federalregister.gov/agencies/industry-and-security-bureau","json_url":"https://www.federalregister.gov/api/v1/agencies/241","parent_id":54,"slug":"industry-and-security-bureau"}],"excerpts":"Authorization Validated End-<span class=\"match\">user</span>.”\n \n \n (3) \n Conditions and Restrictions. \n In evaluating an end <span class=\"match\">user</span> for eligibility under authorization VEU, the ERC will consider a range of information, including but not limited to such factors as: the end <span class=\"match\">user's</span> record of exclusive engagement in appropriate end-use activities; the end <span class=\"match\">user's</span> compliance with U.S. export controls; the need for an on-site review prior to approval; the end <span class=\"match\">user's</span> capability of complying with the requirements of authorization VEU, the ability of the end <span class=\"match\">user</span> to guard against both the"}]}